Gerresheimer invests in the extension of its Medical Plastic Systems business unit

Now the TCC will have an Engi- neering and Sales Center annexed to it.

“We believe there are significant growth opportunities in the medical plastic systems market. One example is the diabetes sector, which gains in significance globally. In the project and solution-oriented medical plastic systems business, the keys to success are quality, competence and individual customer support. By pooling our development, engi- neering and sales competence at one single location we can further improve our service to customers,” commented Uwe Röhrhoff, CEO of Gerresheimer AG.

A two-level building with around 3,000 square meters of total floor space will be annexed to the Technical Competence Center at the Wackersdorf site. Construction work will commence in April 2011 and completion is scheduled for March 2012.

Gerresheimer Medical Plastic Systems is a business unit of the Plastic Systems division which produces insulin pens for diabetics, inhalers, skin-prick aids and disposable laboratory articles for leading pharma, diagnostics and medical technology corporations – from the initial design sketches, through tool making and production to packaging and just-in- time delivery. Gerresheimer operates two Technical Competence Centers for medical plastic systems: a central development center in Wackersdorf and another development center in Peachtree City, Atlanta/USA.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group has production operations at 44 sites in Europe, North and South America and Asia. It realizes revenues of around one billion euros and has 9,500 employees. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.